Prelude Capital Management’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-30,000
Closed -$6.58M 1890
2020
Q2
$6.58M Buy
+30,000
New +$5.99M 0.36% 40
2020
Q1
Sell
-1,800
Closed -$276K 1504
2019
Q4
$276K Sell
1,800
-1,700
-49% -$254K 0.01% 752
2019
Q3
$532K Buy
+3,500
New +$553K 0.02% 500
2019
Q2
Sell
-13,600
Closed -$2.18M 1730
2019
Q1
$2.18M Hold
13,600
0.12% 160
2018
Q4
$2.1M Buy
+13,600
New +$2.12M 0.14% 159
2018
Q1
Sell
-1,000
Closed -$149K 1526
2017
Q4
$149K Sell
1,000
-300
-23% -$40.8K 0.01% 686
2017
Q3
$171K Buy
+1,300
New +$175K 0.02% 701

Other funds holding CLX

Prelude Capital Management's CLX Position: Q4 2021 in Review

Prelude Capital Management sold out of Clorox (CLX) in Q4 2021, closing a stake of 5,654 shares — an estimated $936K sold.

Prelude Capital Management first reported a position in CLX in Q2 2013 and held it in 23 quarters. The position peaked at $2.85M in Q1 2015. 1,220 funds tracked by Wall St. Rank hold CLX as of Q4 2021.

  • Prelude Capital Management reported no remaining Clorox position as of Q4 2021 after selling out during the quarter.
  • Prelude Capital Management sold 5,654 Clorox shares in Q4 2021, an estimated $936K.
  • Prelude Capital Management first reported a position in Clorox in Q2 2013 and held it in 23 quarters.
  • Prelude Capital Management's Clorox position peaked at $2.85M in Q1 2015.
  • 1,220 funds tracked by Wall St. Rank held Clorox as of Q4 2021.

Based on Prelude Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.